Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | S100A4 | P26447 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | PIM1 | P11309 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CTSB | P07858 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10939701 | 0.81 | CYP3A4 (0.56) | CASP6S100A4MEN1KMT2AALDH1A1 | |
| SCHEMBL6610343 | 0.79 | MEN1 (0.42) | MEN1KMT2AALDH1A1PIM1CYP3A4 | |
| SCHEMBL7408400 | 0.76 | CYP3A4 (0.55) | CASP6S100A4MEN1KMT2AALDH1A1 | |
| SCHEMBL12490166 | 0.76 | MAPT (0.45) | MEN1KMT2AALDH1A1PIM1CYP3A4 | |
| SCHEMBL10902960 | 0.72 | AGTR1 (0.47) | MEN1KMT2AALDH1A1PIM1CYP3A4 | |
| SCHEMBL28270294 | 0.71 | CYP19A1 (0.50) | CASP6MEN1KMT2AALDH1A1PIM1 | |
| SCHEMBL3280151 | 0.71 | KDM4E (0.42) | CASP6KMT2AALDH1A1KDM4EMAPT | |
| SCHEMBL9125784 | 0.71 | KDM4E (0.50) | KMT2AALDH1A1CYP3A4KDM4EMAPT | |
| SCHEMBL30790223 | 0.71 | KDM4E (0.50) | KMT2AALDH1A1CYP3A4KDM4EMAPT | |
| SCHEMBL9589546 | 0.71 | KDM4E (0.50) | KMT2AALDH1A1CYP3A4KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080124732-A1 | METHOD FOR OPTICAL MEASUREMENT OF MULTI-STRANDED NUCLEIC ACID | FUJIFILM CORPORATION | 2008-05-29 | — | — | US | disclosed |
| EP-1889880-A2 | Method for optical measurement of multi-stranded nucleic acid | FUJIFILM Corporation (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-1362894-B1 | Method for optical measurement of multi-stranded nucleic acid using cyanine dyes | FUJIFILM CORP (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-20050112770-A1 | Method for optical measurement of multi-stranded nucleic acid | FUJI PHOTO FILM CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| US-6825347-B2 | TRIAZOLE OR IMIDAZOLE OXIDE COMPOUND WITH A POSITIVELY CHARGED ELECTRON WITHDRAWING GROUP (A QUATERNARY NITROGEN CONTAINING AMIDINE OR IMINE GROUP); USEFUL IN EFFECTING THE ACYLATION STEP IN AMIDE FORMATION (PEPTIDE SYNTHESIS) | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2004-11-30 | — | — | US | disclosed |
| EP-1395584-A4 | URONIUM AND IMMONIUM SALTS FOR PEPTIDE COUPLING | CARPINO LOUIS A (US) | 2004-11-03 | — | — | EP | disclosed |
| EP-1395584-A1 | URONIUM AND IMMONIUM SALTS FOR PEPTIDE COUPLING | Carpino, Louis A. (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-1362894-A2 | Method for optical measurement of multi-stranded nucleic acid using cyanine dyes | FUJI PHOTO FILM CO., LTD. (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-20030125561-A1 | Uronium and immonium salts for peptide coupling | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-03 | — | — | US | disclosed |
| WO-2002094822-A1 | URONIUM AND IMMONIUM SALTS FOR PEPTIDE COUPLING | CARPINO LOUIS A (US) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125561-A1 | Uronium and immonium salts for peptide coupling | NGLY1, VIP, IAPP | CASP6 3797/4885S100A4 548/4885MEN1 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.